Utah Medical Products(UTMD)
$73.03+0.17 (+0.23%)
UTMD
Utah Medical Products financials statements
$73.03
At close:+0.17 (+0.23%)
Want to see UTMD full AI Analyst Report?
Utah Medical Products (UTMD) Ratios
123 Followers
Utah Medical Products Ratios
UTMD's free cash flow for Q3 2026 was $0.00. For the 2026 fiscal year, UTMD's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 37.62 | 25.64 | 22.56 | 15.09 | 19.53 |
| Quick Ratio | 34.57 | 23.29 | 20.53 | 13.61 | 17.77 |
| Cash Ratio | 33.01 | 22.09 | 19.72 | 12.59 | 16.28 |
| Solvency Ratio | 4.35 | 3.26 | 3.22 | 2.45 | 2.60 |
| Operating Cash Flow Ratio | 5.66 | 3.95 | 4.73 | 3.55 | 5.66 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 264.84 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 94.47M | $ 91.22M | $ 99.12M | $ 80.30M | $ 64.66M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.03 | 1.04 | 1.06 | 1.08 | 1.08 |
| Debt Service Coverage Ratio | 0.00 | 297.23 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.07 | 0.10 | 0.08 | 0.09 | 0.11 |
| Net Debt to EBITDA | -5.01 | -4.22 | -3.74 | -2.78 | -2.32 |
| Profitability Margins | |||||
| Gross Profit Margin | 57.12% | 59.03% | 59.81% | 61.58% | 63.03% |
| EBIT Margin | 36.63% | 41.08% | 36.71% | 37.85% | 38.49% |
| EBITDA Margin | 44.29% | 47.85% | 49.28% | 51.40% | 53.34% |
| Operating Profit Margin | 29.60% | 33.23% | 33.40% | 37.85% | 38.49% |
| Pretax Profit Margin | 36.63% | 41.08% | 40.00% | 39.52% | 38.86% |
| Net Profit Margin | 29.30% | 33.92% | 33.12% | 31.51% | 30.15% |
| Continuous Operations Profit Margin | 29.30% | 33.92% | 33.12% | 31.51% | 30.15% |
| Net Income Per EBT | 79.99% | 82.57% | 82.81% | 79.74% | 77.58% |
| EBT Per EBIT | 123.75% | 123.60% | 119.74% | 104.39% | 100.96% |
| Return on Assets (ROA) | 9.21% | 11.32% | 12.28% | 13.30% | 12.79% |
| Return on Equity (ROE) | 9.46% | 11.81% | 12.96% | 14.42% | 13.80% |
| Return on Capital Employed (ROCE) | 9.51% | 11.44% | 12.83% | 16.78% | 16.87% |
| Return on Invested Capital (ROIC) | 7.60% | 9.45% | 10.63% | 13.38% | 13.09% |
| Return on Tangible Assets | 10.48% | 13.08% | 14.24% | 16.45% | 17.65% |
| Earnings Yield | 6.22% | 6.44% | 5.43% | 4.51% | 4.05% |
| Efficiency Ratios | |||||
| Receivables Turnover | 10.94 | 9.99 | 14.82 | 9.44 | 9.56 |
| Payables Turnover | 18.13 | 30.87 | 26.25 | 16.49 | 23.83 |
| Inventory Turnover | 2.08 | 1.90 | 2.11 | 2.28 | 2.75 |
| Fixed Asset Turnover | 3.89 | 4.19 | 4.76 | 5.11 | 4.62 |
| Asset Turnover | 0.31 | 0.33 | 0.37 | 0.42 | 0.42 |
| Working Capital Turnover Ratio | 0.41 | 0.42 | 0.54 | 0.68 | 0.77 |
| Cash Conversion Cycle | 188.57 | 216.62 | 183.99 | 176.70 | 155.61 |
| Days of Sales Outstanding | 33.37 | 36.53 | 24.64 | 38.66 | 38.18 |
| Days of Inventory Outstanding | 175.33 | 191.91 | 173.26 | 160.17 | 132.74 |
| Days of Payables Outstanding | 20.13 | 11.83 | 13.90 | 22.13 | 15.31 |
| Operating Cycle | 208.70 | 228.44 | 197.90 | 198.84 | 170.92 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 4.53 | 4.23 | 6.13 | 5.81 | 5.81 |
| Free Cash Flow Per Share | 4.42 | 4.17 | 5.95 | 5.59 | 5.66 |
| Dividend Paid and CapEx Coverage Ratio | 3.37 | 3.30 | 4.53 | 5.31 | 1.76 |
| Capital Expenditure Coverage Ratio | 39.60 | 63.11 | 34.87 | 25.85 | 38.41 |
| Operating Cash Flow Coverage Ratio | 65.30 | 43.88 | 75.53 | 62.01 | 53.54 |
| Operating Cash Flow to Sales Ratio | 0.38 | 0.36 | 0.44 | 0.40 | 0.43 |
| Free Cash Flow Yield | 7.90% | 6.78% | 7.07% | 5.56% | 5.66% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 16.08 | 15.52 | 18.41 | 22.20 | 24.66 |
| Price-to-Sales (P/S) Ratio | 4.71 | 5.26 | 6.10 | 6.99 | 7.43 |
| Price-to-Book (P/B) Ratio | 1.52 | 1.83 | 2.39 | 3.20 | 3.40 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 12.66 | 14.75 | 14.15 | 17.99 | 17.66 |
| Price-to-Operating Cash Flow Ratio | 12.34 | 14.52 | 13.75 | 17.29 | 17.20 |
| Price-to-Earnings Growth (PEG) Ratio | -1.33 | -1.16 | 20.85 | 1.87 | 0.66 |
| Enterprise Value Multiple | 5.61 | 6.78 | 8.63 | 10.83 | 11.62 |
| Enterprise Value | 95.78M | 132.69M | 213.72M | 290.92M | 304.12M |
| EV to EBITDA | 5.61 | 6.78 | 8.63 | 10.83 | 11.62 |
| EV to Sales | 2.49 | 3.24 | 4.26 | 5.56 | 6.20 |
| EV to Free Cash Flow | 6.69 | 9.09 | 9.88 | 14.31 | 14.73 |
| EV to Operating Cash Flow | 6.52 | 8.95 | 9.59 | 13.76 | 14.34 |
| Tangible Book Value Per Share | 32.21 | 28.83 | 30.16 | 24.89 | 20.64 |
| Shareholders’ Equity Per Share | 36.81 | 33.52 | 35.28 | 31.41 | 29.38 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.20 | 0.17 | 0.17 | 0.20 | 0.22 |
| Revenue Per Share | 11.89 | 11.68 | 13.81 | 14.37 | 13.45 |
| Net Income Per Share | 3.48 | 3.96 | 4.57 | 4.53 | 4.05 |
| Tax Burden | 0.80 | 0.83 | 0.83 | 0.80 | 0.78 |
| Interest Burden | 1.00 | 1.00 | 1.09 | 1.04 | 1.01 |
| Research & Development to Revenue | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
| SG&A to Revenue | 0.26 | 0.14 | 0.22 | 0.20 | 0.21 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.30 | 1.07 | 1.34 | 1.28 | 1.43 |
Currency in USD
